Three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement-mediated attack
about
sameAs
Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44.The transcription factor LSF: a novel oncogene for hepatocellular carcinomaSix genes expressed in bones and teeth encode the current members of the SIBLING family of proteinsExpression of dentin matrix protein 1 in tumors causing oncogenic osteomalaciaExpression of SIBLINGs and their partner MMPs in salivary glandsPhosphophoryn regulates the gene expression and differentiation of NIH3T3, MC3T3-E1, and human mesenchymal stem cells via the integrin/MAPK signaling pathwayA chondroitin sulfate chain attached to the bone dentin matrix protein 1 NH2-terminal fragmentEndoplasmic reticulum chaperone protein GRP-78 mediates endocytosis of dentin matrix protein 1The interaction between factor H and Von Willebrand factor.Dentin phosphoprotein binds annexin 2 and is involved in calcium transport in rat kidney ureteric bud cellsMolecular energy dissipation in nanoscale networks of Dentin Matrix Protein 1 is strongly dependent on ion valence.Different forms of DMP1 play distinct roles in mineralization.Intrinsically disordered proteins and biomineralization.Complement control protein factor H: the good, the bad, and the inadequate.Osteopontin: roles in implantation and placentation.Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancerBone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancerCD10 and osteopontin expression in dentigerous cyst and ameloblastoma.The role of complement in tumor growthDentin matrix protein 1 (DMP1) signals via cell surface integrin.Dentin matrix proteins and soluble factors: intrinsic regulatory signals for healing and resorption of dental and periodontal tissues?Clinical use of markers of bone turnover in metastatic bone disease.Developing Potential Candidates of Preclinical Preeclampsia.The role of orthodontic tooth movement in bone and root mineral density: a study of patients submitted and not submitted to orthodontic treatmentBone sialoprotein binding to matrix metalloproteinase-2 alters enzyme inhibition kinetics.Pathogenic role of Fgf23 in Dmp1-null mice.Transgenic expression of Dspp partially rescued the long bone defects of Dmp1-null mice.Structural requirements for bone sialoprotein binding and modulation of matrix metalloproteinase-2.Dentin matrix protein-1 isoforms promote differential cell attachment and migration.The use of molecular markers of bone turnover in the management of patients with metastatic bone disease.Small integrin-binding proteins as serum markers for prostate cancer detectionRole of matrix vesicles in biomineralization.The role of acidic phosphoproteins in biomineralization.Osteopontin in macrophage function.Downregulation of osteopontin and bone sialoprotein II is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cells.Hypomorphic conditional deletion of E11/Podoplanin reveals a role in osteocyte dendrite elongation.Evidence for direct amelogenin-target cell interactions using dynamic force spectroscopy.Factor H binds to platelet integrin alphaIIbbeta3.In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions.[SIBLING proteins: molecular tools for tumor progression and angiogenesis].
P2860
Q24538982-72862570-6499-4F53-AC0C-CE6BD17A2ADEQ24613885-4C29553A-CF5F-4497-BF94-99F88EE4BE00Q28204658-61A39CBD-D35D-460E-86C2-989FC157FC3AQ28248572-7CB430EF-D8E4-4100-8B07-F383CA37911EQ28278825-734FAF61-A990-4772-BE9D-61D934902126Q28282477-DDCB200E-F3BF-4401-9803-0AAA2124728BQ28292467-D364AEC4-48EF-41C5-86B8-1228C791C02FQ28582772-3B714D51-EB06-4A57-AD9A-BC05D9F55608Q31133820-9CEBF633-9581-4F48-A79E-CA3632215397Q33112077-FB79180E-96B3-4BFD-BC2F-CAFD84959A0BQ33374806-5ED15623-9E90-4233-9213-A9D881E0D4B0Q33862348-86DF0FDE-5D78-4668-AAC3-8B4E642E0029Q34045958-48D8EA4C-0051-4F1A-B768-C92CE67EAC27Q34067107-A752C269-6FC7-410B-80BD-3DD1A54DDCBCQ34218572-AF730B0F-83BA-4798-AAAD-CD3D774ABC53Q34655823-0F7B0DF2-B700-4A5B-8929-520EAAF4CD2BQ34909724-671FC283-CD2E-4ACA-98AF-E50D06F44C7AQ35054580-03553F87-82A6-4178-B00A-A572D3DD66E0Q35231345-5DA696D4-ABDC-4A23-BBFB-97C78BBEC452Q35313348-10BF837A-6534-43F8-86C9-9D8F3469B73FQ35680422-019C151F-5DD4-4648-9690-50D76198082CQ36277211-2955BE8E-3E9A-4E25-BC73-125142F0F259Q36324699-38B54CAA-B04F-4E2E-B763-B804F63986D7Q36577630-A86492BB-5F1B-4375-AB1F-E6B3C67FD132Q36791863-5C6F68D0-A64E-47F0-ACBE-D7586B291412Q36846110-42587FAD-35DE-4C3E-8094-F964D2AC033EQ36923585-55761A1D-E748-416B-8DDA-334853AA7C72Q36952540-4065F43F-8638-43C0-9C0B-0F80A0DAE404Q36973689-E8DC687D-ACB0-4091-9925-DD621135F2DEQ36990793-121DD8C2-EC1F-4DD2-BF82-515E6ADDD3BFQ37397529-83870666-9CB6-4FA1-96CE-ACFC12767D59Q37440044-33F47177-E644-4390-AB33-92F5AF39924FQ37733702-1B754039-1524-47B4-97AC-6B6CF28AE4CFQ37872380-A0A68627-669A-4F74-B1E0-F0FA15DC10CAQ38347522-5E0B4347-9DEA-410F-B20C-F186AD5D86E0Q38794651-A83A6E0E-D5AA-4274-AD97-F370F8F8D8EDQ40283926-DCD521CC-8D7C-4A47-B01C-B27D85C3628FQ46268349-12B56ABB-8745-4661-A0D2-6D02C31386E1Q47212064-A36EAB0E-B7E6-45AB-80D6-58353C6792E8Q54530705-1AC5B7AC-E55E-4BFC-B274-E3D86EC01C71
P2860
Three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement-mediated attack
description
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2002
@ast
im April 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 19 April 2002)
@en
vedecký článok (publikovaný 2002/04/19)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/04/19)
@nl
наукова стаття, опублікована у квітні 2002
@uk
name
Three SIBLINGs (small integrin ...... of complement-mediated attack
@ast
Three SIBLINGs (small integrin ...... of complement-mediated attack
@en
Three SIBLINGs (small integrin ...... of complement-mediated attack
@nl
type
label
Three SIBLINGs (small integrin ...... of complement-mediated attack
@ast
Three SIBLINGs (small integrin ...... of complement-mediated attack
@en
Three SIBLINGs (small integrin ...... of complement-mediated attack
@nl
prefLabel
Three SIBLINGs (small integrin ...... of complement-mediated attack
@ast
Three SIBLINGs (small integrin ...... of complement-mediated attack
@en
Three SIBLINGs (small integrin ...... of complement-mediated attack
@nl
P2093
P2860
P356
P1476
Three SIBLINGs (small integrin ...... of complement-mediated attack
@en
P2093
Abdullah Karadag
Berthold Fohr
Larry W Fisher
P2860
P304
P356
10.1074/JBC.M110757200
P407
P50
P577
2002-04-19T00:00:00Z